SCHEMBL26332091

SCHEMBL26332091

Cc1cc(Nc2ccnc3ccc(P)cc23)ccc1C(=O)Nc1cccc(Nc2ccncc2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 2/20 0.54
MAPT P10636 2/20 0.54
KMT2A Q03164 2/20 0.54
KDM4E B2RXH2 1/20 0.54
ALDH1A1 P00352 1/20 0.54
POLB P06746 1/20 0.54
THRB P10828 1/20 0.54
MAPK1 P28482 1/20 0.54
MCL1 Q07820 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
DNMT1 P26358 10/20 0.52
DNMT3A Q9Y6K1 7/20 0.52
DNMT3L Q9UJW3 5/20 0.48
EGFR P00533 3/20 0.46
EHMT1 Q9H9B1 3/20 0.43
KDR P35968 1/20 0.41
MYC P01106 1/20 0.41
MAP2K3 P46734 1/20 0.41
EHMT2 Q96KQ7 1/20 0.41
DNMT3B Q9UBC3 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26314528 0.91 USP2 (0.55) USP2MAPTKMT2AKDM4EALDH1A1
SCHEMBL24003837 0.89 MAPT (0.54) USP2MAPTKMT2AKDM4EALDH1A1
SCHEMBL24003754 0.87 USP2 (0.51) USP2MAPTKMT2AKDM4EALDH1A1
SCHEMBL26332088 0.86 DNMT1 (0.52) USP2MAPTKMT2AKDM4EALDH1A1
SCHEMBL26314582 0.85 USP2 (0.54) USP2MAPTKMT2AKDM4EALDH1A1
SCHEMBL26331749 0.85 DNMT1 (0.52) USP2MAPTKMT2AKDM4EALDH1A1
SCHEMBL26331722 0.84 DNMT1 (0.69) USP2MAPTKMT2AKDM4EALDH1A1
SCHEMBL23999381 0.83 USP2 (0.59) USP2MAPTKMT2AKDM4EALDH1A1
SCHEMBL24006111 0.82 DNMT1 (0.66) USP2MAPTKMT2AKDM4EALDH1A1
SCHEMBL24003982 0.82 DNMT1 (0.66) USP2MAPTKMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295114-A1 AKT3 MODULATORS Georgiamune Inc. 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295114-A1 AKT3 MODULATORS AKT3, AKT2, MTOR USP2 3789/4885MAPT 3962/4885KMT2A 3925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.